The possible heart dangers of the diabetes drug Avandia are in the news again. An FDA advisory panel is in the midst of a two day hearing on the drug and it’s possible cardiac dangers.

More evidence has surfaced that suggests that the drug manufacturer (GlaxoSmithKline) knew about the possible heart risks as early as 2001 but withheld the information. The company claims that the information concerning them withholding cardiac risks was “cherry picked” from nearly 14 million pages of documents and is untrue.

If you take Avandia you need to pay close attention to these hearings. A decision will eventually be made that could range from stronger warnings on the drug label to possible removal from the market. bjmdjd

Material modifications since posting: July 16, 2010

Avandia · Food and Drug Administration · GlaxoSmithKline

No comments yet.

<< Update On Avandia

Tylenol, Motrin, and Benadryl Recall Grows >>